c-myc but not Hif-1α-dependent downregulation of VEGF influences the proliferation and differentiation of HL-60 cells induced by ATRA

Oncology Reports

Volumn 29, Issue 6, 2013, Pages 2378-2384

  Song, Guanhua ^a   Li, Yanmei ^a   Zhang, Zhiyong ^a   Ren, Xia ^a   Li, Hongjiang ^a   Zhang, Wen ^a   Wei, Ruoying ^a   Pan, Sufei ^a   Shi, Lulu ^a   Bi, Kehong ^b   Jiang, Guosheng ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

c Myc; Differentiation; HL 60; Proliferation; Vascular endothelial growth factor

Indexed keywords

CD11B ANTIGEN; CYCLOOXYGENASE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MYC PROTEIN; PROTEIN C JUN; PROTEIN P53; RETINOIC ACID; SMALL INTERFERING RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR SP1; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CELL ASSAY; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HL 60; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HL-60 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRETINOIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84876224678     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2395     Document Type: Article

References (22)

1. Olsson AK, Dimberg A, Kreuger J and Claesson-Welsh L: VEGF receptor signaling - in control of vascular function. Nat Rev Mol Cell Biol 7: 359-371, 2006.
2. Podar K and Anderson KC: The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications. Blood 105: 1383-1395, 2005. (Pubitemid 40223651)
3. Mayerhofer M, Valent P, Sperr WR, Griffin JD and Sillaber C: BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin. Blood 100: 3767-3775, 2002. (Pubitemid 35303950)
4. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E and Folkman J: Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 150: 815-821, 1997. (Pubitemid 27106153)
5. Ghosh AK, Shanafelt TD, Cimmino A, et al: Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. Blood 113: 5568-5574, 2009.
6. Jiang GS, Yang WH, Wen PE, Ren X, Tang TH and Ren HQ: HIF-1α independent down-regulation of VEGF expression in HL60 cells after in vitro exposure to ATRA. Blood 110: 4290, 2007.
7. Lidgren A, Hedberg Y, Grankvist K, Torgny R, Vasko J and Ljungberg B: The expression of hypoxia-inducible factor 1alpha is a favorable independent prognostic factor in renal cell carcinoma. Clin Cancer Res 11: 1129-1135, 2005. (Pubitemid 40175762)
8. Schuch G, Machluf M, Bartsch G Jr, et al: In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. Blood 100: 4622-4628, 2002. (Pubitemid 35429707)
9. Ter Elst A, Ma B, Scherpen FJ, et al: Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia. Cancer Res 71: 2761-2771, 2011.
10. Weidenaar AC, ter Elst A, Koopmans-Klein G, et al: High acute myeloid leukemia derived VEGFA levels are associated with a specific vascular morphology in the leukemic bone marrow. Cell Oncol 34: 289-296, 2011.
11. Bajpai J, Sharma A, Kumar L, et al: Acute promyelocytic leukemia: an experience from a tertiary care centre in north India. Indian J Cancer 48: 316-322, 2011.
12. Tee MK, Vigne JL and Taylor RN: All-trans retinoic acid inhibits vascular endothelial growth factor expression in a cell model of neutrophil activation. Endocrinology 147: 1264-1270, 2006. (Pubitemid 43244359)
13. Wang ES, Teruya-Feldstein J, Wu Y, Zhu Z, Hicklin DJ and Moore MA: Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo. Blood 104: 2893-2902, 2004. (Pubitemid 39434977)
14. Vaupel P: The role of hypoxia-induced factors in tumor progression. Oncologist 9 (Suppl 5): 10-17, 2004.
15. Ohno H, Shirato K, Sakurai T, et al: Effect of exercise on HIF-1 and VEGF signaling. J Phys Fitness Sports Med 1: 5-16, 2012.
16. Loeffler S, Fayard B, Weis J and Weissenberger J: Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int J Cancer 115: 202-213, 2005. (Pubitemid 40586728)
17. Xie K, Wei D, Shi Q and Huang S: Constitutive and inducible expression and regulation of vascular endothelial growth factor. Cytokine Growth Factor Rev 15: 297-324, 2004. (Pubitemid 39140697)
18. Colla S, Tagliaferri S, Morandi F, et al: The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis. Blood 110: 4464-4475, 2007. (Pubitemid 351377813)
19. Lee CC, Chen SC, Tsai SC, et al: Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells. J Biomed Sci 13: 143-156, 2006.
20. Mizukami Y, Fujiki K, Duerr EM, et al: Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-kinase/Rho/ROCK and c-Myc. J Biol Chem 281: 13957-13963, 2006. (Pubitemid 43848321)
21. Dadiani M, Seger D, Kreizman T, et al: Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc. Endocr Relat Cancer 16: 819-834, 2009.
22. Yang Y, Hu Y, Wang Y, Li J, Liu F and Huang L: Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung cancer. Mol Pharm: Jun 22, 2012 (Epub ahead of print).